World Conference on Regenerative Medicine: Last chance for abstract submission – Deadline extension until June 24, 2013

The deadline for submitting abstracts to the World Conference on Regenerative Medicine taking place 23 - 25 October in Leipzig has been extended to 24 June. More information is available online at About 1,000 international scientists, physicians and entrepreneurs will talk about latest developments and research results in the field of stem cell technologies, cell therapy, biomaterials and tissue engineering.

Logo World Conference on Regenerative Medicine
© Fraunhofer IZI

For Leipzig’s conference, one of the most renowned stem cell researchers from the partner country Canada, Mick Bhatia could be acquired. His talk entitled “Differentiation and Conversion of Human Cell Fate: Plasticity and Pluripotency” will be part of the opening event on Wednesday evening. The highly reputable German stem cell researcher Hans Schöler is also going to attend the evening program. His lecture will bring deeper information on iPS (induced pluripotent stem) cells and noval approaches for their application on treatment of neurodegenerative diseases. Further scientific highlights are the talks of Irvin Weissman and Robert Lanza on the topics “Normal and tumor stem cells” and “Embryonic stem cells and iPS on the way to the clinic”.

In addition to the scientific program, the event will serve as a platform for informal exchanges and networking. A versatile evening program with an opening event, a get-together, a poster party and a social evening event in the Gondwanaland, Europe's largest tropical experience world in Leipzig Zoo, offers participants the possibility to network with their colleagues in science and business.

Abstracts can be submitted until 24 June. Registration, abstract submission and ticket booking for the social event will be made online on the conference website

The World Conference on Regenerative Medicine is taking place for the sixth consecutive time. Every two years, the Conference is organized by the Fraunhofer Institute for Cell Therapy and Immunology IZI and the Translational Centre for Regenerative Medicine (TRM) of the Universität Leipzig.